Skip to content
10-K

Annual Report

XG SCIENCES INC

0001731122-21-001620

← back to feed
Filed
Sep 30, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Aug 30, 2021 2.49M sh
Capex FY 2020 · Dec 31, 2020 $47.53K
Capex FY 2020 · Dec 31, 2019 $383.07K
Operating Cash Flow FY 2020 · Dec 31, 2020 −$4.78M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$8.59M
Long Term Debt FY 2020 · Dec 31, 2020 $12.78M
Long Term Debt FY 2020 · Dec 31, 2019 $8.11M
Cash And Equivalents FY 2020 · Dec 31, 2020 $1.77M
Cash And Equivalents FY 2020 · Dec 31, 2019 $1.13M
Stockholders Equity FY 2020 · Dec 31, 2020 −$7.68M
Stockholders Equity FY 2020 · Dec 31, 2019 −$2.15M
Current Liabilities FY 2020 · Dec 31, 2020 $1.62M
Current Liabilities FY 2020 · Dec 31, 2019 $1.39M
Total Liabilities FY 2020 · Dec 31, 2020 $15.04M
Total Liabilities FY 2020 · Dec 31, 2019 $10.69M
Current Assets FY 2020 · Dec 31, 2020 $2.63M
Current Assets FY 2020 · Dec 31, 2019 $2.43M
Total Assets FY 2020 · Dec 31, 2020 $7.35M
Total Assets FY 2020 · Dec 31, 2019 $8.54M
Sga Expense FY 2020 · Dec 31, 2020 $4.22M
Sga Expense FY 2020 · Dec 31, 2019 $5.47M
Rd Expense FY 2020 · Dec 31, 2020 $896.84K
Rd Expense FY 2020 · Dec 31, 2019 $1.51M
Net Income FY 2020 · Dec 31, 2020 −$7.1M
Net Income FY 2020 · Dec 31, 2019 −$9.78M
Operating Income FY 2020 · Dec 31, 2020 −$7M
Operating Income FY 2020 · Dec 31, 2019 −$9.37M
Gross Profit FY 2020 · Dec 31, 2020 −$1.88M
Gross Profit FY 2020 · Dec 31, 2019 −$2.39M
Cost Of Revenue FY 2020 · Dec 31, 2020 $2.66M
Cost Of Revenue FY 2020 · Dec 31, 2019 $3.76M
Revenue FY 2020 · Dec 31, 2020 $782.69K
Revenue FY 2020 · Dec 31, 2019 $1.37M